Skip to main content
Caplight Logo









Epsilon Molecular Engineering, Inc.

Epsilon Molecular Engineering, Inc.

Private
SaitamaHealthcare & Life Scienceshttps://www.epsilon-mol.co.jp/

Last Round

Series B

May 29, 2026

Est. Valuation

$20.35M

Total Funding Raised

$5.5M

Company Overview

Epsilon Molecular Engineering, Inc. is a biotechnology company that conducts research and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

VHH antibodiescDNA displaynanobodiesantibody discoveryhigh-throughput screeningdrug discoverybiotherapeuticsantibody librarycontract research organizationCROsingle-domain antibodiesantibody engineeringAI drug discoverycyclic peptidesin-silico designmolecular engineeringbispecific antibodies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epsilon Molecular Engineering, Inc. Comparables

Compare Epsilon Molecular Engineering, Inc. with similar companies based on industry and business-model similarity.

Epsilon Molecular Engineering, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Isogenica
83%
株式会社イーベック
72%
PeptiDream Inc.
71%

Epsilon Molecular Engineering, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 29, 2026
Series ADec 23, 2020
SeedNov 13, 2017

Epsilon Molecular Engineering, Inc. Investors

Notable investors and investment history

Epsilon Molecular Engineering, Inc. investors
InvestorRounds
株式会社日本政策金融公庫Series B
Mitsubishi UFJ CapitalSeries A
UntroD Capital Japan Inc.Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2024

    Monthly visitors increased 280% MoM, reaching 9.5K.

  • Dec 23, 2020

    $5.5M round led by Mitsubishi UFJ Capital.

Epsilon Molecular Engineering, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epsilon Molecular Engineering, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epsilon Molecular Engineering, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSaitama
Employee Range6
Year Founded2016
Last FundingMay 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?